Evidence map›Paper›PMID 40724900›Full record

ReviewInternational journal of molecular sciences2025

Immune Microenvironment in Oral Potentially Malignant Disorders and Oral Cancer: A Narrative Review.

Aiman Ali, Graziella Rigueira Molska, Huiling Yeo, Najmeh Esfandiari, Will Jeong, Michelle Huang, Marco Magalhaes

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aiman AliFaculty of Dentistry, University of Toronto, Toronto, ON M5G1G6, Canada.ORCID 0000-0002-9580-2094
Graziella Rigueira MolskaFaculty of Dentistry, University of Toronto, Toronto, ON M5G1G6, Canada.
Huiling YeoFaculty of Dentistry, University of Toronto, Toronto, ON M5G1G6, Canada.
Najmeh EsfandiariFaculty of Dentistry, University of Toronto, Toronto, ON M5G1G6, Canada.
Will JeongSchulich School of Medicine & Dentistry, Western University, London, ON N6A5C1, Canada.
Michelle HuangFaculty of Dentistry, University of Toronto, Toronto, ON M5G1G6, Canada.ORCID 0000-0002-7063-6042
Marco MagalhaesFaculty of Dentistry, University of Toronto, Toronto, ON M5G1G6, Canada.ORCID 0000-0002-5060-7738

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple studies have investigated the impact of the tumor immune microenvironment (TIME) on oral squamous cell carcinoma (OSCC), with most focusing on three key cellular components: lymphocytes, macrophages, and neutrophils, as well as the molecular mechanisms underlying inflammation-mediated OSCC invasion. Although the specific roles of each cell type vary depending on their subtypes and the characteristics of OSCC, several consistent patterns have been identified. TIME plays a critical role at every stage of OSCC progression, from tumor initiation and growth to invasion and metastasis. Understanding the communication signals-the language-between tumor cells and the TIME, encoded through various proteins secreted by immune cells, is essential for controlling tumor progression and developing effective treatments for OSCC. This review provides an overview of how TIME influences the progression of the Oral Potentially Malignant Disorders (OPMDs) to OSCC as well as OSCC's invasion, focusing on the contributions of various immune cells within the TIME. Additionally, we discuss recent advances in immunotherapy for OSCC, highlighting strategies to enhance immune responses and improve treatment outcomes.

Indexed as

Carcinoma, Squamous CellMouth NeoplasmsTumor MicroenvironmentAnimalsDisease ProgressionHumansImmunotherapyimmune cellsinflammationOPMDsOSCCtumor immune microenvironment

Identifiers

PMID40724900
PMCPMC12294717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.